Nexturn Bio Inc. decided to invest in the development of a new...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SEOUL, South Korea, May 7, 2021 /PRNewswire-AsiaNet/ -- Has significantly reduced side effects of the current diabetes drugs on the market Maximize effectiveness by reducing drug and insulin resistance from long-term useNexturn Bio Inc., a subsidiary of Nexturn Bioscience Co., Ltd. (KOSDAQ:8914...
Authors: LATEST ASIANET NEWS RELEASES